These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 23705792)
21. Protective effect of valsartan against doxorubicin-induced cardiotoxicity: Histopathology and metabolomics in vivo study. Alhazzani K; Alotaibi MR; Alotaibi FN; Aljerian K; As Sobeai HM; Alhoshani AR; Alanazi AZ; Alanazi WA; Alswayyed M J Biochem Mol Toxicol; 2021 Sep; 35(9):e22842. PubMed ID: 34273911 [TBL] [Abstract][Full Text] [Related]
22. Nanometronomic treatment of 4T1 breast cancer with nanocaged doxorubicin prevents drug resistance and circumvents cardiotoxicity. Mazzucchelli S; Bellini M; Fiandra L; Truffi M; Rizzuto MA; Sorrentino L; Longhi E; Nebuloni M; Prosperi D; Corsi F Oncotarget; 2017 Jan; 8(5):8383-8396. PubMed ID: 28039473 [TBL] [Abstract][Full Text] [Related]
23. Selective A3 adenosine receptor agonist protects against doxorubicin-induced cardiotoxicity. Galal A; El-Bakly WM; Al Haleem EN; El-Demerdash E Cancer Chemother Pharmacol; 2016 Feb; 77(2):309-22. PubMed ID: 26676227 [TBL] [Abstract][Full Text] [Related]
24. Protective effects of mito-TEMPO against doxorubicin cardiotoxicity in mice. Rocha VC; França LS; de Araújo CF; Ng AM; de Andrade CM; Andrade AC; Santos Ede S; Borges-Silva Mda C; Macambira SG; Noronha-Dutra AA; Pontes-de-Carvalho LC Cancer Chemother Pharmacol; 2016 Mar; 77(3):659-62. PubMed ID: 26712129 [TBL] [Abstract][Full Text] [Related]
25. α-Bisabolol Attenuates Doxorubicin Induced Renal Toxicity by Modulating NF-κB/MAPK Signaling and Caspase-Dependent Apoptosis in Rats. Arunachalam S; Nagoor Meeran MF; Azimullah S; Jha NK; Saraswathiamma D; Subramanya S; Albawardi A; Ojha S Int J Mol Sci; 2022 Sep; 23(18):. PubMed ID: 36142441 [TBL] [Abstract][Full Text] [Related]
26. Cardiotoxicity of doxorubicin/paclitaxel combination in rats: effect of sequence and timing of administration. Saad SY; Najjar TA; Alashari M J Biochem Mol Toxicol; 2004; 18(2):78-86. PubMed ID: 15122649 [TBL] [Abstract][Full Text] [Related]
28. Cardioprotective effects of melatonin and metformin against doxorubicin-induced cardiotoxicity in rats are through preserving mitochondrial function and dynamics. Arinno A; Maneechote C; Khuanjing T; Ongnok B; Prathumsap N; Chunchai T; Arunsak B; Kerdphoo S; Shinlapawittayatorn K; Chattipakorn SC; Chattipakorn N Biochem Pharmacol; 2021 Oct; 192():114743. PubMed ID: 34453902 [TBL] [Abstract][Full Text] [Related]
29. Protective effect of tetrandrine on doxorubicin-induced cardiotoxicity in rats. Xu M; Sheng L; Zhu X; Zeng S; Chi D; Zhang GJ Tumori; 2010; 96(3):460-4. PubMed ID: 20845809 [TBL] [Abstract][Full Text] [Related]
30. Protective effects of tannic acid on acute doxorubicin-induced cardiotoxicity: Involvement of suppression in oxidative stress, inflammation, and apoptosis. Zhang J; Cui L; Han X; Zhang Y; Zhang X; Chu X; Zhang F; Zhang Y; Chu L Biomed Pharmacother; 2017 Sep; 93():1253-1260. PubMed ID: 28738542 [TBL] [Abstract][Full Text] [Related]
31. Sulforaphane potentiates anticancer effects of doxorubicin and attenuates its cardiotoxicity in a breast cancer model. Bose C; Awasthi S; Sharma R; Beneš H; Hauer-Jensen M; Boerma M; Singh SP PLoS One; 2018; 13(3):e0193918. PubMed ID: 29518137 [TBL] [Abstract][Full Text] [Related]
32. Electrocardiographic and biochemical evidence for the cardioprotective effect of antioxidants in acute doxorubicin-induced cardiotoxicity in the beagle dogs. Xin Y; Zhang S; Gu L; Liu S; Gao H; You Z; Zhou G; Wen L; Yu J; Xuan Y Biol Pharm Bull; 2011; 34(10):1523-6. PubMed ID: 21963490 [TBL] [Abstract][Full Text] [Related]
33. Metformin potentiates the chemotherapeutic effects of doxorubicin on 2-amino-1-methyl-6-phenylimidazo[4,5b] pyridine-induced Mammary Carcinoma in rats. Salim E; El-Sisi AE; Sokar S; El-Sayad M; Moussa E Fundam Clin Pharmacol; 2021 Aug; 35(4):700-713. PubMed ID: 32905620 [TBL] [Abstract][Full Text] [Related]
34. In vivo evaluation of a new polymer-lipid hybrid nanoparticle (PLN) formulation of doxorubicin in a murine solid tumor model. Wong HL; Rauth AM; Bendayan R; Wu XY Eur J Pharm Biopharm; 2007 Mar; 65(3):300-8. PubMed ID: 17156986 [TBL] [Abstract][Full Text] [Related]
35. Inhibition of N-methyl-N-nitrosourea-induced mammary carcinogenesis by molecular iodine (I2) but not by iodide (I-) treatment Evidence that I2 prevents cancer promotion. García-Solís P; Alfaro Y; Anguiano B; Delgado G; Guzman RC; Nandi S; Díaz-Muñoz M; Vázquez-Martínez O; Aceves C Mol Cell Endocrinol; 2005 May; 236(1-2):49-57. PubMed ID: 15922087 [TBL] [Abstract][Full Text] [Related]
36. QbD-based development of α-linolenic acid potentiated nanoemulsion for targeted delivery of doxorubicin in DMBA-induced mammary gland carcinoma: in vitro and in vivo evaluation. Tripathi CB; Parashar P; Arya M; Singh M; Kanoujia J; Kaithwas G; Saraf SA Drug Deliv Transl Res; 2018 Oct; 8(5):1313-1334. PubMed ID: 29748834 [TBL] [Abstract][Full Text] [Related]
37. General oxidative stress during doxorubicin-induced cardiotoxicity in rats: absence of cardioprotection and low antioxidant efficiency of alpha-lipoic acid. Ghibu S; Delemasure S; Richard C; Guilland JC; Martin L; Gambert S; Rochette L; Vergely C Biochimie; 2012 Apr; 94(4):932-9. PubMed ID: 21396425 [TBL] [Abstract][Full Text] [Related]
39. [Treatment of rabbits bearing advanced VX2 tumors in the mammary gland with nano-sized liposomal adriamycin administered by various routes]. Chen JH; Li Y; Yao Q; Ling R; Wang L; Li KZ; Wang Z; Chen T Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3039-42. PubMed ID: 16324402 [TBL] [Abstract][Full Text] [Related]
40. The role of hesperidin as a cardioprotective strategy against doxorubicin-induced cardiotoxicity: The antioxidant, anti-inflammatory, antiapoptotic, and cytoprotective potentials. Alharbi FK; Alshehri ZS; Alshehri FF; Alhajlah S; Khalifa HA; Dahran N; Ghonimi WAM Open Vet J; 2023 Dec; 13(12):1718-1728. PubMed ID: 38292716 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]